MedTrace Logo

Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication

NCT04741906 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2024-08-21

No results posted yet for this study

Summary

Aim of the study is to examine the feasibility of dental implant insertion in patients receiving high, adjuvant and low dose \> 4 years.

Conditions

Interventions

PROCEDURE

Dental implant surgery

Dental surgery in patients treated with antiresorptive medication

PROCEDURE

Prosthetic treatment

Prosthetic treatment and loading of the dental implants

Sponsors & Collaborators

  • Amgen

    collaborator INDUSTRY

  • Institut Straumann AG

    collaborator INDUSTRY

  • Copenhagen University Hospital at Herlev

    lead OTHER

Principal Investigators

  • Sanne Werner Moeller Andersen, DDS · Copenhagen University Hospital, Maxillofacial surgery

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04741906 on ClinicalTrials.gov